Page last updated: 2024-09-04

cp 55244 and piperidines

cp 55244 has been researched along with piperidines in 2 studies

Compound Research Comparison

Studies (cp 55244)	Trials (cp 55244)	Recent Studies (post-2010) (cp 55244)	Studies (piperidines)	Trials (piperidines)	Recent Studies (post-2010) (piperidines)
13	0	1	40,235	5,221	14,545

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abood, ME; Griffin, G; Martin, BR; Wray, EJ	1
Cartier, E; Edwards, JL; Howlett, AC; Shim, JY; Welsh, WJ	1

Other Studies

2 other study(ies) available for cp 55244 and piperidines

Article	Year
Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British journal of pharmacology, 1999, Volume: 128, Issue:3 Topics: Allosteric Regulation; Animals; Benzoxazines; Cerebellum; Male; Morpholines; Naphthalenes; Piperidines; Protein Binding; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant	1999
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor. Journal of medicinal chemistry, 2002, Mar-28, Volume: 45, Issue:7 Topics: Algorithms; Animals; Brain; Kinetics; Ligands; Models, Chemical; Models, Molecular; Naphthalenes; Piperidines; Protein Binding; Protein Conformation; Protons; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Software; Structure-Activity Relationship	2002

Article

Year

Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.

British journal of pharmacology, 1999, Volume: 128, Issue:3

Topics: Allosteric Regulation; Animals; Benzoxazines; Cerebellum; Male; Morpholines; Naphthalenes; Piperidines; Protein Binding; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

1999

Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.

Journal of medicinal chemistry, 2002, Mar-28, Volume: 45, Issue:7

Topics: Algorithms; Animals; Brain; Kinetics; Ligands; Models, Chemical; Models, Molecular; Naphthalenes; Piperidines; Protein Binding; Protein Conformation; Protons; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Software; Structure-Activity Relationship

2002